HIGHLIGHTS
- who: Miao-Ling Chen from the University of Campania Luigi Vanvitelli, Italy have published the research: Transarterial chemoembolization combined with metformin improves the prognosis of hepatocellular carcinoma patients with type 2 diabetes, in the Journal: (JOURNAL)
- what: Early recurrence is still the main reason for poor long-term survival after TACE.
- how: The results showed that the longer duration of metformin use was not associated with a lower risk of death as well as a lower recurrence after adjusting for BCLC stage and BMI level as shown in Table S1.
- future . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.